A project for the future

The Consortium for the Early Identification of Alzheimer’s Disease (CIMA-Q) brings together more than 90 Quebec researchers and clinicians who share the common goal of advancing knowledge about Alzheimer’s disease. More specifically, our mission is to develop tools to detect the first signs of its appearance. The early identification of Alzheimer’s disease greatly increases the likelihood of successful interventions, thus improving the quality of life for seniors struggling with this terrible condition. …read more


Expert Groups and Platforms

The purpose of CIMA-Q is to promote and potentiate Québec’s expertise in research on Alzheimer’s disease. The Consortium has set up expert groups and platforms whose mission is the identification of reliable and sensitive predictive cognitive tests, the discovery of new neuroimaging markers, the identification of new biomarkers and therapeutic targets and of risk factors and preventive factors. …read more


Become a member of CIMA-Q

CIMA-Q members benefit from expertise with CIMA-Q Principal Investigators, will be informed of scientific training activities. In addition, members will be invited to scientific symposia to engage in knowledge transfer activities.…read more